This pharmaceutical company develops oral, small-molecule therapies, primarily for chronic electrolyte imbalances, including chronic elevated levels of phosphate and potassium.
This pharmaceutical company develops oral, small-molecule therapies, primarily for chronic electrolyte imbalances, including chronic elevated levels of phosphate and potassium.